HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 102.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,000 | +16.7% | 6,388 | +43.6% | 0.00% | – |
Q2 2023 | $24,000 | – | 4,448 | +88860.0% | 0.00% | – |
Q1 2023 | $0 | – | 5 | -16.7% | 0.00% | – |
Q4 2022 | $0 | – | 6 | -25.0% | 0.00% | – |
Q3 2022 | $0 | – | 8 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 8 | -99.7% | 0.00% | – |
Q1 2022 | $15,000 | -73.2% | 2,414 | -70.1% | 0.00% | – |
Q4 2021 | $56,000 | +80.6% | 8,062 | +81.1% | 0.00% | – |
Q3 2021 | $31,000 | +24.0% | 4,452 | +47.6% | 0.00% | – |
Q2 2021 | $25,000 | +56.2% | 3,017 | +2.4% | 0.00% | – |
Q1 2021 | $16,000 | -15.8% | 2,947 | -35.0% | 0.00% | – |
Q4 2020 | $19,000 | +533.3% | 4,534 | +353.4% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 1,000 | -3.5% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 1,036 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 1,036 | +1.6% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 1,020 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | +50.0% | 1,020 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -93.1% | 1,020 | -84.7% | 0.00% | – |
Q1 2019 | $29,000 | +480.0% | 6,667 | +299.9% | 0.00% | – |
Q4 2018 | $5,000 | -58.3% | 1,667 | -25.0% | 0.00% | – |
Q3 2018 | $12,000 | +140.0% | 2,222 | +118.1% | 0.00% | – |
Q2 2018 | $5,000 | -50.0% | 1,019 | -51.2% | 0.00% | – |
Q1 2018 | $10,000 | +42.9% | 2,090 | 0.0% | 0.00% | – |
Q4 2017 | $7,000 | – | 2,090 | +4650.0% | 0.00% | – |
Q1 2017 | $0 | – | 44 | -27.9% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 61 | -99.4% | 0.00% | – |
Q3 2016 | $27,000 | +92.9% | 10,000 | +100.0% | 0.00% | – |
Q2 2016 | $14,000 | -48.1% | 5,000 | -44.4% | 0.00% | – |
Q1 2016 | $27,000 | -35.7% | 9,000 | -25.9% | 0.00% | – |
Q4 2015 | $42,000 | -17.6% | 12,147 | -10.2% | 0.00% | – |
Q3 2015 | $51,000 | -36.2% | 13,530 | -3.8% | 0.00% | – |
Q2 2015 | $80,000 | +14.3% | 14,067 | +17.2% | 0.00% | – |
Q1 2015 | $70,000 | +2.9% | 12,000 | 0.0% | 0.00% | – |
Q4 2014 | $68,000 | +38.8% | 12,000 | 0.0% | 0.00% | – |
Q3 2014 | $49,000 | -10.9% | 12,000 | 0.0% | 0.00% | – |
Q2 2014 | $55,000 | -3.5% | 12,000 | 0.0% | 0.00% | – |
Q1 2014 | $57,000 | +103.6% | 12,000 | +100.0% | 0.00% | – |
Q4 2013 | $28,000 | +2700.0% | 6,000 | +2453.2% | 0.00% | – |
Q3 2013 | $1,000 | – | 235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |